Clinical Trials Directory

Trials / Completed

CompletedNCT01022632

Effect of Curcumin as Nutraceutical in Patients of Depression

A Randomized, Active Controlled, Open Label, Parallel Group Study to Compare the Efficacy of Extract of Curcuma Longa (Turmeric) With Fluoxetine and to Study Its Effect as an Add on Therapy to Fluoxetine in Patients of Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Government Medical College, Bhavnagar · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find the effect of commonly used nutraceutical curcumin ( extract of Curcuma longa, commonly called 'Haldi' in Hindi) in patients of depression.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCurcuminCurcumin 500 mg 12 hourly after taking food in morning and evening for 6 weeks
DRUGFluoxetineFluoxetine ; 20 mg Once a day in morning after taking food for 6 weeks
DIETARY_SUPPLEMENTCurcumin and FluoxetineCurcumin 500 12 hourly after taking food in morning and evening and Fluoxetine 20 mg Once a day in morning after taking food for 6 weeks

Timeline

Start date
2009-03-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2009-12-01
Last updated
2010-01-28

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01022632. Inclusion in this directory is not an endorsement.